New Delhi: Convalescent plasma did not prevent disease progression in high-risk group of covid-19 outpatients when administered within the first week of their symptoms, showed final results of a clinical trial funded by National Institutes of Health (NIH), US ...
from Google Alert - health https://ift.tt/3z28lIW
via IFTTT
0 comments:
Post a Comment